West Palm Beach, FL (PRWEB) November 28, 2011
In January 2012 the MPN Research Foundation will be hosting an MPN patient symposium in West Palm Beach, Florida. This event will be an opportunity for patients with myeloproliferative neoplasms (polycythemia vera, essential thrombocythemia and myelofibrosis) to hear from top doctors and researchers in the field and have questions answered.
This event is taking place on January 10, 2012 at the West Palm Beach Marriott, 1001 Okeechobee Blvd, West Palm Beach, FL 33401. Speakers for the event will include Dr. Ronald Hoffman, Mount Sinai Medical Center, Dr. Robert J. Jacobson, Palm Beach Cancer Institute, Dr. Ross Levine, Memorial Sloan-Kettering Cancer Center, Dr. Ruben Mesa, Mayo Clinic, Dr. Srdan Verstovsek, MD Anderson Cancer Center, Stephanie Cindric, ET Patient. Additional speakers will be announced at a later date.
The fee for this event is $125 per person. The cost for each additional guest is $75. The registration fee includes a continental breakfast, lunch and two snacks. Patients attending this symposium will learn the latest research developments and treatment practices from a panel of distinguished MPN researchers and physicians.
Registration is currently open. Space is extremely limited and it is recommended that anyone interested should purchase tickets in advance to ensure their space at the 2012 MPN Research Foundation’s West Palm Beach Symposium.
Purchase tickets: http://www.mpnresearchfoundation.org/West-Palm-Beach-Patient-Symposium
The MPN Research Foundation was founded in 2000 by a group of patients who were not satisfied with how little research was being conducted on the myeloproliferative neoplasms in America and that no advocacy groups were working to promote medical research for the MPNs. This group of four patients formed what was at the time the only non-profit organization dedicated to helping MPN patients live longer and enjoy a better quality of life by encouraging and funding new research into the causes and potential cures for the MPNs polycythemia vera, primary myelofibrosis and essential thrombocythemia.
Founded by patients, for patients, terms on every research grant are negotiated to maximize the dollars invested in actual research. The Foundation’s esteemed Scientific Advisory Board utilizes a rigorous selection process to ensure donations are allocated to the most innovative research projects. The scientific advisory board includes highly regarded physicians from Scripps, University of Utah, BC Cancer Research Center and Weill Cornell.
To date, the Foundation has awarded over eight million dollars for MPN. While the priority remains on funding innovative and accountable research, efforts to educate and empower the MPN community of patients, family members, doctors and researchers continue with events such as the West Palm Beach Symposia.
MPN Research Foundation
180 N. Michigan Avenue, Suite 1870
Chicago, IL 60601